An Observational Registry to Evaluate the Incidence of and Risk Factors for Vascular Occlusive Events Associated With ICLUSIG®

Clinical trial NCT02455024 · TERMINATED

Trial details

NCT number: NCT02455024
Sponsor: Ariad Pharmaceuticals
Status: TERMINATED
Study type: OBSERVATIONAL

Myeloid Leukemia, Chronic-Phase, Accelerated-Phase, Blast-Phase, Ph+ALL

Start date: 2018-03-02
Primary completion: 2019-02-19
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.